Exact Mass: 922.4007038000001

Exact Mass Matches: 922.4007038000001

Found 24 metabolites which its exact mass value is equals to given mass value 922.4007038000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Vincristine Sulfate

C46H56N4O10. H2SO4 (922.3670048)

Same as: D02197 Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM. Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM.

Vintec

methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((3S,5S,7S,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate sulfate

C46H56N4O10.H2SO4 (922.3670048)

Vincristine sulfate appears as an anticancer drug. White to slightly yellow, amorphous or crystalline powder. Sensitive to light. Odorless. pH (0.1\\\\% solution) 3.5 - 4.5. (NTP, 1992) Vincristine Sulfate is the sulfate salt of a natural alkaloid isolated from the plant Catharanthus roseus (Vinca rosea L.) with antimitotic and antineoplastic activities. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca(2+)-activated ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) See also: Vincristine (has active moiety). D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM. Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM.

Keramamide J

C43H58N10O11S (922.4007038000001)

Vincristine Sulfate

methyl (1S,10S,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid

C46H58N4O14S (922.3670048)

D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids Origin: Plant; SubCategory_DNP: Alkaloids derived from tryptophan, Secologanin typtamine alkaloids, Indole alkaloids Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM. Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM.

16alpha-[(6-O-sulfo-beta-D-glucopyranosyl)oxy]pregn-5-en-20-ol-3beta-yl O-(2-O-acetyl-beta-D-digitalopyranosyl)-(1->4)-beta-D-cymaropyranoside

C43H70O19S (922.4231790000001)

1-O-<2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyl-(1--->2)-alpha-L-arabinopyranosyl>-epitrillogenin-24-O-acetate|1-O-[2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyl-(1--->2)-alpha-L-arabinopyranosyl]-epitrillogenin-24-O-acetate

1-O-<2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyl-(1--->2)-alpha-L-arabinopyranosyl>-epitrillogenin-24-O-acetate|1-O-[2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyl-(1--->2)-alpha-L-arabinopyranosyl]-epitrillogenin-24-O-acetate

C45H62O20 (922.3834251999999)

Vintec

C46H56N4O10.H2O4S (922.3670048)

Vincristine

Vincristine Sulfate

C46H58N4O14S (922.3670048)

Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM. Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM.

VINCRISTINE SULFATE_major

C46H58N4O14S (922.3670048)

VINCRISTINE SULFATE_25.6\\%

C46H58N4O14S (922.3670048)

LPIM2 18:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C39H71O22P (922.4174395999999)

(3-Phenyl-1H-inden-1-ylidene)bis(tricyclohexylphosphine)ruthenium(IV) dichloride tetrahydrofuran adduct

C51H76Cl2P2Ru (922.3842416000001)

N4,N4-bis[4-(Diphenylamino)phenyl]-N4,N4-di-1-naphthalenyl-[1,1-biphenyl]-4,4-diamine

C68H50N4 (922.4035259999999)

methyl (1S,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid

methyl (1S,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid

C46H58N4O14S (922.3670048)

Vintec

C46H56N4O10. H2SO4 (922.3670048)

Vincristine sulfate appears as an anticancer drug. White to slightly yellow, amorphous or crystalline powder. Sensitive to light. Odorless. pH (0.1\\\\% solution) 3.5 - 4.5. (NTP, 1992) Vincristine Sulfate is the sulfate salt of a natural alkaloid isolated from the plant Catharanthus roseus (Vinca rosea L.) with antimitotic and antineoplastic activities. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca(2+)-activated ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) See also: Vincristine (has active moiety). D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids Same as: D02197 Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM. Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM.

(1'r,2s,3s,4s,4'r,5s,7'r,8'r,12's,13'r,14'r,16'r)-14'-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4r,5s,6s)-3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,16'-dihydroxy-7'-(hydroxymethyl)-5,13'-dimethyl-3'-oxo-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-2'(9'),18'-dien-4-yl acetate

(1'r,2s,3s,4s,4'r,5s,7'r,8'r,12's,13'r,14'r,16'r)-14'-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4r,5s,6s)-3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,16'-dihydroxy-7'-(hydroxymethyl)-5,13'-dimethyl-3'-oxo-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-2'(9'),18'-dien-4-yl acetate

C45H62O20 (922.3834251999999)

(2r,3r)-n-[(2s,6s,9r,12s,16s,19e)-6-[(2r)-butan-2-yl]-8,11,15,18-tetrahydroxy-16-(1h-indol-3-ylmethyl)-2-(methoxymethyl)-9-methyl-4,5-dioxo-23-thia-3,7,10,14,17,24-hexaazabicyclo[19.2.1]tetracosa-1(24),7,10,14,17,19,21-heptaen-12-yl]-2-{[(2r)-1,2-dihydroxy-3-[(hydroxymethylidene)amino]propylidene]amino}-3-methylpentanimidic acid

(2r,3r)-n-[(2s,6s,9r,12s,16s,19e)-6-[(2r)-butan-2-yl]-8,11,15,18-tetrahydroxy-16-(1h-indol-3-ylmethyl)-2-(methoxymethyl)-9-methyl-4,5-dioxo-23-thia-3,7,10,14,17,24-hexaazabicyclo[19.2.1]tetracosa-1(24),7,10,14,17,19,21-heptaen-12-yl]-2-{[(2r)-1,2-dihydroxy-3-[(hydroxymethylidene)amino]propylidene]amino}-3-methylpentanimidic acid

C43H58N10O11S (922.4007038000001)

14'-[(4,5-dihydroxy-3-{[3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}oxan-2-yl)oxy]-3,16'-dihydroxy-7'-(hydroxymethyl)-5,13'-dimethyl-3'-oxo-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-2'(9'),18'-dien-4-yl acetate

14'-[(4,5-dihydroxy-3-{[3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}oxan-2-yl)oxy]-3,16'-dihydroxy-7'-(hydroxymethyl)-5,13'-dimethyl-3'-oxo-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-2'(9'),18'-dien-4-yl acetate

C45H62O20 (922.3834251999999)

[(2r,3s,4s,5r,6r)-6-{[(1s,2r,3as,3bs,7s,9ar,9bs,11as)-7-{[(2r,4s,5r,6r)-5-{[(2s,3r,4s,5s,6r)-3-(acetyloxy)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid

[(2r,3s,4s,5r,6r)-6-{[(1s,2r,3as,3bs,7s,9ar,9bs,11as)-7-{[(2r,4s,5r,6r)-5-{[(2s,3r,4s,5s,6r)-3-(acetyloxy)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid

C43H70O19S (922.4231790000001)

(2r,3r)-3-{[(2r)-2-{[(2s,3s)-2-[(4-amino-1,3-dihydroxybutylidene)amino]-3-carboxy-1,3-dihydroxypropylidene]amino}-6-carbamimidamido-1-hydroxyhexylidene]amino}-2-hydroxy-3-{[(1s)-2-hydroxy-1-{[(1s)-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}-4-(n-hydroxyacetamido)butyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}propanoic acid

(2r,3r)-3-{[(2r)-2-{[(2s,3s)-2-[(4-amino-1,3-dihydroxybutylidene)amino]-3-carboxy-1,3-dihydroxypropylidene]amino}-6-carbamimidamido-1-hydroxyhexylidene]amino}-2-hydroxy-3-{[(1s)-2-hydroxy-1-{[(1s)-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}-4-(n-hydroxyacetamido)butyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}propanoic acid

C34H58N12O18 (922.3991848000001)

[6-({7-[(5-{[3-(acetyloxy)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl)oxy]-1-(1-hydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl}oxy)-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid

[6-({7-[(5-{[3-(acetyloxy)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl)oxy]-1-(1-hydroxyethyl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl}oxy)-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid

C43H70O19S (922.4231790000001)